Filtered By:
Specialty: Endocrinology
Management: Insurance
Countries: China Health

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 3 results found since Jan 2013.

EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China
ConclusionThe diabetes complications and comorbidities among patients with type  2 diabetes were associated with poor health utility scores, especially for those with diabetic foot, stroke, and nephropathy.
Source: Diabetes Therapy - March 8, 2020 Category: Endocrinology Source Type: research

Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
Conclusions World population is aging and the increase in life expectancy is often unhealthy. In particular, musculoskeletal aging, which leads to sarcopenia and osteoporosis, has several causes such as changes in body composition, inflammation, and hormonal imbalance. Sarcopenia, osteoporosis, and more frequently, sarcopenic obesity are commonly associated with aging and frequently closely linked each other, often leading to the development of a frailty syndrome. Frailty syndrome favors an increased risk of loss function in daily activities, for cardiovascular diseases, cancers, falls, and mortality. As the number of eld...
Source: Frontiers in Endocrinology - April 23, 2019 Category: Endocrinology Source Type: research

Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China
ConclusionsManaging complications results in substantial costs to the Chinese healthcare system. Our study contributes towards quantifying the economic burden and supports the parametrization of economic models of diabetes in China.
Source: Diabetes Therapy - November 18, 2020 Category: Endocrinology Source Type: research